Lara Sullivan - Jan 3, 2023 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
Chief Executive Officer, Director
Signature
/s/ Pamela Connealy, Attorney-in-Fact for Lara Sullivan
Stock symbol
PYXS
Transactions as of
Jan 3, 2023
Transactions value $
$0
Form type
4
Date filed
1/3/2023, 06:39 PM
Previous filing
Apr 15, 2022
Next filing
Mar 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PYXS Common Stock Award $0 +95.7K +7.05% $0.00 1.45M Jan 3, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest on April 13, 2023, subject to the Reporting Person's continued employment through the vesting date.